Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis

doi:10.1001/jamaoncol.2015.5871

. 2016 Apr;2(4):543-5.

doi: 10.1001/jamaoncol.2015.5871.

Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis

Firas Abdollah¹, Maxine Sun², Jesse D Sammon¹, Toni K Choueiri³, Mani Menon¹, Joel S Weissman⁴, Quoc-Dien Trinh²

Affiliations

¹ Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.
² Division of Urologic Surgery, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts3Center for Surgery and Public Health, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical.
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
⁴ Center for Surgery and Public Health, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

PMID: 26794060
DOI: 10.1001/jamaoncol.2015.5871

Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis

Firas Abdollah et al. JAMA Oncol. 2016 Apr.

. 2016 Apr;2(4):543-5.

doi: 10.1001/jamaoncol.2015.5871.

Authors

Firas Abdollah¹, Maxine Sun², Jesse D Sammon¹, Toni K Choueiri³, Mani Menon¹, Joel S Weissman⁴, Quoc-Dien Trinh²

Affiliations

¹ Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.
² Division of Urologic Surgery, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts3Center for Surgery and Public Health, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical.
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
⁴ Center for Surgery and Public Health, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

PMID: 26794060
DOI: 10.1001/jamaoncol.2015.5871

No abstract available

PubMed Disclaimer

Cited by

Cancer Screening of Older Adults in Israel According to Life Expectancy: Cross Sectional Study.
Bareket R, Schonberg MA, Comaneshter D, Schonmann Y, Shani M, Cohen A, Vinker S. Bareket R, et al. J Am Geriatr Soc. 2017 Nov;65(11):2539-2544. doi: 10.1111/jgs.15035. Epub 2017 Sep 5. J Am Geriatr Soc. 2017. PMID: 28875497 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis

Affiliations

Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical